These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Dubner S; Auricchio A; Steinberg JS; Vardas P; Stone P; Brugada J; Piotrowicz R; Hayes DL; Kirchhof P; Breithardt G; Zareba W; Schuger C; Aktas MK; Chudzik M; Mittal S; Varma N Europace; 2012 Feb; 14(2):278-93. PubMed ID: 22232544 [TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
7. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association. Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012 [TBL] [Abstract][Full Text] [Related]
8. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Slotwiner D; Varma N; Akar JG; Annas G; Beardsall M; Fogel RI; Galizio NO; Glotzer TV; Leahy RA; Love CJ; McLean RC; Mittal S; Morichelli L; Patton KK; Raitt MH; Ricci RP; Rickard J; Schoenfeld MH; Serwer GA; Shea J; Varosy P; Verma A; Yu CM Heart Rhythm; 2015 Jul; 12(7):e69-100. PubMed ID: 25981148 [No Abstract] [Full Text] [Related]
9. Actions elicited during scheduled and unscheduled in-hospital follow-up of cardiac devices: results of the ATHENS multicentre registry. Mascioli G; Curnis A; Landolina M; Klersy C; Gelmini GP; Ruffa F; Europace; 2011 Dec; 13(12):1766-73. PubMed ID: 21764815 [TBL] [Abstract][Full Text] [Related]
10. Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs. Theuns DAMJ; Radhoe SP; Brugts JJ Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071624 [TBL] [Abstract][Full Text] [Related]
11. Emerging Implantable-Device Technology for Patients at the Intersection of Electrophysiology and Heart Failure Interdisciplinary Care. Mastoris I; Spall HGCV; Sheldon SH; Pimentel RC; Steinkamp L; Shah Z; Al-Khatib SM; Singh JP; Sauer AJ J Card Fail; 2022 Jun; 28(6):991-1015. PubMed ID: 34774748 [TBL] [Abstract][Full Text] [Related]
12. An interactive assistant for patients with cardiac implantable electronic devices: A study protocol of the LUCY trial. Michalik J; Cacko A; Poliński J; Pawlik K; Tataj E; Gawałko M; Opolski G; Grabowski M Medicine (Baltimore); 2018 Sep; 97(39):e12556. PubMed ID: 30278555 [TBL] [Abstract][Full Text] [Related]
13. One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator. Ishii N; Nakajima K; Kakuta T; Noda T; Fujita T; Kusano K Intern Med; 2021 Jun; 60(12):1877-1880. PubMed ID: 33518564 [TBL] [Abstract][Full Text] [Related]
14. Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in Women. Ignaszewski MT; Daugherty SL; Russo AM Heart Fail Clin; 2019 Jan; 15(1):109-125. PubMed ID: 30449374 [TBL] [Abstract][Full Text] [Related]
16. The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study. Ching CK; Hsieh YC; Liu YB; Rodriguez DA; Kim YH; Joung B; Singh B; Huang D; Hussin A; Chasnoits AR; O'Brien JE; Cerkvenik J; Lexcen D; Van Dorn B; Zhang S J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2285-2294. PubMed ID: 34216069 [TBL] [Abstract][Full Text] [Related]
17. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M; Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135 [TBL] [Abstract][Full Text] [Related]
18. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224 [TBL] [Abstract][Full Text] [Related]
19. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Dubner S; Auricchio A; Steinberg JS; Vardas P; Stone P; Brugada J; Piotrowicz R; Hayes DL; Kirchhof P; Breithardt G; Zareba W; Schuger C; Aktas MK; Chudzik M; Mittal S; Varma N Ann Noninvasive Electrocardiol; 2012 Jan; 17(1):36-56. PubMed ID: 22276627 [TBL] [Abstract][Full Text] [Related]
20. Effects of exercise training on physical activity in heart failure patients treated with cardiac resynchronization therapy devices or implantable cardioverter defibrillators. Yanagi H; Konishi H; Yamada S; Kitagaki K; Nakanishi M; Harada T; Kohzuki M J Rehabil Med; 2020 Oct; 52(10):jrm00111. PubMed ID: 32830281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]